Wells Fargo lowered the firm’s price target on Exelon to $39 from $41 and keeps an Equal Weight rating on the shares. The stock’s earnings multiple discount relative to peers is “fair” in of light of regulatory and balance sheet considerations, the analyst tells investors in a research note. Aside from Illinois, the remaining 75% of Exelon’s operations are “doing quite well”, the firm added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on EXC: